ArticleACR open rheumatology2024

Patterns in the Sequential Treatment of Patients With Rheumatoid Arthritis Starting a Biologic or Targeted Synthetic Disease-Modifying Antirheumatic Drug: 10-Year Experience From a US-Based Registry.

Anton Matsson et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.